Growth Metrics

Bio-Rad Laboratories (BIO-B) Other Working Capital Changes (2009 - 2017)

Bio-Rad Laboratories (BIO-B) reported Other Working Capital Changes of $29.6 million for Q3 2017, up 332.53% year-over-year from $6.9 million in Q3 2016, and up 528.63% on a QoQ basis from -$6.9 million in Q2 2017.

Bio-Rad Laboratories (BIO-B) has 9 years of Other Working Capital Changes data on file, last reported at $29.6 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Bio-Rad Laboratories - - 309.40 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2017 29.63 Mn
Sep 30, 2017 29.63 Mn
Jun 30, 2017 -6.91 Mn
Jun 30, 2017 -6.91 Mn
Mar 31, 2017 -3.98 Mn
Mar 31, 2017 -3.98 Mn
Sep 30, 2016 -12.74 Mn
Sep 30, 2016 -12.74 Mn
Jun 30, 2016 -13.17 Mn
Jun 30, 2016 -13.17 Mn
Mar 31, 2016 15.73 Mn
Mar 31, 2016 15.73 Mn
Sep 30, 2015 -7.79 Mn
Sep 30, 2015 -7.79 Mn
Jun 30, 2015 3.68 Mn
Jun 30, 2015 3.68 Mn
Mar 31, 2015 1.49 Mn
Mar 31, 2015 1.49 Mn
Sep 30, 2014 -12.85 Mn
Sep 30, 2014 -12.85 Mn
Jun 30, 2014 -8.03 Mn
Jun 30, 2014 -8.03 Mn
Mar 31, 2014 11.39 Mn
Mar 31, 2014 11.39 Mn
Sep 30, 2013 12.21 Mn
Sep 30, 2013 12.21 Mn
Jun 30, 2013 -17.62 Mn
Jun 30, 2013 -17.62 Mn
Mar 31, 2013 11.16 Mn
Mar 31, 2013 11.16 Mn
Sep 30, 2012 7.79 Mn
Sep 30, 2012 7.79 Mn
Jun 30, 2012 -8.04 Mn
Jun 30, 2012 -8.04 Mn
Mar 31, 2012 4.62 Mn
Mar 31, 2012 4.62 Mn
Sep 30, 2011 15.68 Mn
Sep 30, 2011 15.68 Mn
Jun 30, 2011 -20.65 Mn
Jun 30, 2011 -20.65 Mn
Mar 31, 2011 8.47 Mn
Mar 31, 2011 8.47 Mn
Sep 30, 2010 -13.05 Mn
Sep 30, 2010 -13.05 Mn
Jun 30, 2010 25.82 Mn
Jun 30, 2010 25.82 Mn
Mar 31, 2010 -9.21 Mn
Mar 31, 2010 -9.21 Mn
Sep 30, 2009 635,000.00
Sep 30, 2009 635,000.00